NEWS
GE HEALTHCARE UNVEILS ENHANCED VOLUSON EXPERT SERIES WOMEN ’ S HEALTH ULTRASOUND SYSTEMS WITH FOCUS ON EARLY DETECTION AND EXAM EFFICIENCY
GE HealthCare has announced it has received 510 ( k ) clearance from the United States Food and Drug Administration ( FDA ) for the updated portfolio of Voluson Expert Series ultrasound systems . Voluson Expert 22 , 20 , and 18 combine high-resolution image quality with advanced ultrasound technology and an ergonomic design for efficient workflow and a world-class user experience . The Voluson Expert Series integrates Artificial Intelligence ( AI ) -powered features and automation tools to help drive imaging performance and efficiencies in women ’ s healthcare . these complications are left undetected or untreated , it may harm the mother or the baby . The growing prevalence of these complications [ ii ] underscores the need for innovative solutions that enable early detection and intervention .
The Voluson Expert Series , GE HealthCare ’ s most advanced women ’ s health ultrasound systems , offers premium ultrasound imaging for confident diagnoses for high-risk , complex pregnancies . The Lyric Architecture is designed to unlock new imaging and processing power to deliver detailed and uniform images and reveal finer details within the anatomy with ease , even in difficult scanning conditions . AI-enabled functionality and automation tools are available to support faster assessments and early detection , diagnosis and intervention .
Approximately 30,000 to 50,000 women in the United States experience complex , high-risk pregnancies each year . When
JOHNSON & JOHNSON MEDTECH LAUNCHES CEREGLIDE 92 CATHETER SYSTEM FOR ACUTE ISCHEMIC STROKE
Johnson & Johnson MedTech , an emerging leader in neurovascular care , has announced the launch of the CEREGLIDE 92 Catheter System , a next-generation . 092 ” catheter with the INNERGLIDE 9 delivery aid , indicated for use in facilitating the insertion and guidance of interventional devices in the neurovascular system . CEREGLIDE 92 is a . 092 ” inner diameter catheter system that allows physicians to achieve large distal access and is designed to provide flow reduction in the M1 when inserting devices for the revascularisation of patients with acute ischaemic stroke . The larger lumen also provides distal support for multiple neurovascular tools when treating aneurysms and other haemorrhagic complications . CEREGLIDE 92 is the latest catheter in Johnson & Johnson MedTech ’ s growing catheter portfolio designed to integrate with Stroke Solutions , such as CEREGLIDE 71 , PROWLER EX and EMBOTRAP III .
Acute ischaemic strokes account for 85 % of all strokes worldwide , and the M1 territory is the most commonly affected by stroke . By utilising CEREGLIDE 92 to insert aspiration catheters during thrombectomy procedures , physicians can restore blood flow in the brain by directly withdrawing a blood clot or inserting a catheter in combination with a stent retriever .
Dr Brian Jankowitz , Chief of Neurosurgery and Co-Chair of the Stroke and Neurovascular Programme at the Hackensack Meridian Neuroscience Institute at JFK University Medical Centre , said : “ As an early user of CEREGLIDE 92 and INNERGLIDE 9 , this super large-bore catheter system helps provide quick and seamless access to the M1 with the benefit of flow control , allowing us to rapidly reperfuse the patient and extend the benefits of next-generation stroke technology to more patients .”
www . intelligenthealth . tech 7